Unknown

Dataset Information

0

Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands.


ABSTRACT: Metastasis displays a highly heterogeneous cellular population with cancer cells continuously evolving. As a result, a single-ligand nanoparticle cannot account for the continuously changing expression of targetable biomarkers over time and space. To effectively direct nanoparticles to metastasis, we developed a multi-ligand nanoparticle by using four different types of ligands on the same nanoparticle that target biomarkers on the endothelium associated with metastatic disease. These vascular targets included ?v?3 integrin, P-selectin, EGFR and fibronectin. Using terminal and in vivo imaging studies, the targeting performance of the multi-ligand nanoparticles was compared to the single-ligand nanoparticle variants. All four single-ligand nanoparticle variants achieved significant targeting of lung metastasis in the 4T1 mouse model of breast cancer metastasis with about 2.5% of the injected dose being deposited into metastasis. A dual-ligand nanoparticle resulted in a nearly 2-fold higher deposition into lung metastases than its single-ligand counterparts. The multi-ligand nanoparticle significantly outperformed its targeting nanoparticle counterparts achieving a deposition of ?7% of its injected nanoparticles into lung metastases. Using the high sensitivity of radionuclide imaging, PET imaging showed that a multi-ligand nanoparticle labeled with [18F]fluoride was able to precisely target metastatic disease at its very early stage of development in three different animal models of metastatic breast cancer.

SUBMITTER: Peiris PM 

PROVIDER: S-EPMC5908762 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands.

Peiris P M PM   He F F   Covarrubias G G   Raghunathan S S   Turan O O   Lorkowski M M   Gnanasambandam B B   Wu C C   Schiemann W P WP   Karathanasis E E  

Nanoscale 20180401 15


Metastasis displays a highly heterogeneous cellular population with cancer cells continuously evolving. As a result, a single-ligand nanoparticle cannot account for the continuously changing expression of targetable biomarkers over time and space. To effectively direct nanoparticles to metastasis, we developed a multi-ligand nanoparticle by using four different types of ligands on the same nanoparticle that target biomarkers on the endothelium associated with metastatic disease. These vascular t  ...[more]

Similar Datasets

| S-EPMC7828255 | biostudies-literature
| S-EPMC6612825 | biostudies-literature
| S-EPMC5078994 | biostudies-literature
| S-EPMC4579532 | biostudies-literature
| S-EPMC2592073 | biostudies-literature
| S-EPMC7271158 | biostudies-literature
| S-EPMC8435610 | biostudies-literature
| S-EPMC7944478 | biostudies-literature
| S-EPMC8179109 | biostudies-literature
| S-EPMC3343697 | biostudies-other